| 000 | 02836 a2200769 4500 | ||
|---|---|---|---|
| 005 | 20250514062059.0 | ||
| 264 | 0 | _c20030527 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a1537-3649 | ||
| 024 | 7 |
_a10.1385/IJGC:32:1:7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHashimoto, Koji | |
| 245 | 0 | 0 |
_aPeroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. _h[electronic resource] |
| 260 |
_bInternational journal of gastrointestinal cancer _c2002 |
||
| 300 |
_a7-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a3T3 Cells _xdrug effects |
| 650 | 0 | 4 |
_aAdenocarcinoma _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCadherins _xbiosynthesis |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 | _aCaspase 8 |
| 650 | 0 | 4 | _aCaspase 9 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aCell Division _xdrug effects |
| 650 | 0 | 4 | _aCollagen |
| 650 | 0 | 4 |
_aCyclin D1 _xbiosynthesis |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p21 |
| 650 | 0 | 4 | _aCyclin-Dependent Kinase Inhibitor p27 |
| 650 | 0 | 4 |
_aCyclins _xbiosynthesis |
| 650 | 0 | 4 | _aCyclooxygenase 2 |
| 650 | 0 | 4 |
_aCytoskeletal Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xbiosynthesis |
| 650 | 0 | 4 | _aLaminin |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 | _aMembrane Proteins |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xdrug effects |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aProstaglandin D2 _xanalogs & derivatives |
| 650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xbiosynthesis |
| 650 | 0 | 4 | _aProteoglycans |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xdrug effects |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 | _aThiazolidinediones |
| 650 | 0 | 4 |
_aTrans-Activators _xbiosynthesis |
| 650 | 0 | 4 |
_aTranscription Factors _xdrug effects |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aalpha Catenin |
| 650 | 0 | 4 | _abeta Catenin |
| 700 | 1 | _aEthridge, Richard T | |
| 700 | 1 | _aEvers, B Mark | |
| 773 | 0 |
_tInternational journal of gastrointestinal cancer _gvol. 32 _gno. 1 _gp. 7-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1385/IJGC:32:1:7 _zAvailable from publisher's website |
| 999 |
_c12425684 _d12425684 |
||